Product Pipeline

PV-10 Clinical Development Program

Indication

Pre-Clinical

Phase 1

Phase 2

Phase 3

Status

 
 
 
 
 
 
  • Orphan drug status obtained in January 2007
  • Phase 1/2 combination study in progress
  • Phase 3 study in progress: Opened recruitment in April 2015
 
 
 
 
 
 
  • Orphan drug status obtained in April 2011
  • Phase 1 protocol ongoing
 
 
 
 
 
 
  • Phase 1 study completed
 
 
 
 
 
 
  • Phase 1 study ongoing

Other Solid
Tumors

 
 
 
 
 
 
  • Other cancer indications and combinations are planned

Pediatric Tumors

 
 
 
 
 
 
  • Collaboration with POETIC for pre-clinical evaluation in pediatric tumor models
Apple App Store Google Play Store
NEWSLETTER
Errors